Deep Brain Stimulators (DBS) Market Forecast Report To 2020: Grand View Research, Inc.

Global Deep Brain Stimulators (DBS) Market By Application (Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder, Depression, Dystonia, Parkinson’s Disease) Expected To Reach USD 1.59 billion By 2020

Global deep brain stimulators market is expected to reach USD 1.59 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of target neurological disorders such as Parkinson’s and demand for minimally invasive surgical procedures are some primary factors expected to drive the deep brain stimulators market. Deep brain stimulators have witnessed a significant rise in usage rates and are now considered viable substitutes to conventional therapies. Higher efficacy exhibited by the former is a key reason attributing to the aforementioned conclusion. Introduction of technological advancements such as fractionation of electric current and selective current steering are also expected to improve device usage rates.Deep brain stimulators are FDA approved when it comes to treating Parkinson’s, dystonia and OCD (obsessive compulsive disorder) etc. Moreover, the use of these devices for diseases such as trigeminal neuralgia, Tourette syndrome, Alzheimer’s, refractory epilepsy, cluster headache and movement disorders by multiple sclerosis are awaiting FDA approval. The potential inclusion of new application areas is expected fuel the future growth of the market. View summary of this report @ http://www.grandviewresearch.com/industryanalysis/deep-brain-stimulators-dbs-market

Global deep brain stimulators market, by region, 2012 â&#x20AC;&#x201C; 2020 (USD Million)

Table of Contents Chapter 1. Executive Summary 1.1. Deep brain stimulatorsâ&#x20AC;&#x201C; Industry Summary and Critical Success Factors (CSFs) Chapter 2. Deep brain stimulators Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Deep Brain Stimulators Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Deep brain stimulators- Company Market Share Analysis 2.7. Deep brain stimulators Market PESTEL Analysis, 2012 Chapter 3. Deep Brain Stimulators Application Outlook

3.1. Pain Management 3.1.1. Market Estimates and Forecasts, 2012 – 2020 (USD Million) 3.2. Epilepsy 3.2.1. Market Estimates and Forecasts, 2012 – 2020 (USD Million) 3.3. Essential Tremor 3.3.1. Market Estimates and Forecasts, 2012 – 2020 (USD Million) 3.4. Obsessive Compulsive Disorder (OCD) 3.4.1. Market Estimates and Forecasts, 2012 – 2020 (USD Million) 3.5. Depression 3.5.1. Market Estimates and Forecasts, 2012 – 2020 (USD Million) 3.6. Dystonia 3.6.1. Market Estimates and Forecasts, 2012 – 2020 (USD Million) 3.7. Parkinson’s Disease 3.7.1. Market Estimates and Forecasts, 2012 – 2020 (USD Million) 3.8. Others 3.8.1. Market Estimates and Forecasts, 2012 – 2020 (USD Million) Chapter 4. Deep Brain Stimulators Regional Outlook 4.1. North America 4.1.1. North America Market Estimates and Forecasts, by Application, 2012 – 2020 (USD Million) 4.1.2. U.S. Market Estimates and Forecasts, by Application, 2012 – 2020 (USD Million) 4.2. Europe 4.2.1. Europe Market Estimates and Forecasts, by Application, 2012 – 2020 (USD Million)

4.2.2. UK Market Estimates and Forecasts, by Application, 2012 – 2020 (USD Million) 4.2.3. Germany Market Estimates and Forecasts, by Application, 2012 – 2020 (USD Million) 4.3. Asia Pacific 4.3.1. Asia Pacific Market Estimates and Forecasts, by Application, 2012 – 2020 (USD Million) 4.3.2. Japan Market Estimates and Forecasts, by Application, 2012 – 2020 (USD Million) 4.4. RoW 4.4.1. RoW Market Estimates and Forecasts, by Application, 2012 – 2020 (USD Million) Chapter 5. Competitive Landscape 5.1. Medtronic Plc 5.1.1. Revenue Analysis 5.1.2. Product Benchmarking 5.1.3. Strategic Development 5.2. Boston Scientific 5.2.1. Revenue Analysis 5.2.2. Product Benchmarking 5.2.3. Strategic Development 5.3. St. Jude Medical, Inc. 5.3.1. Revenue Analysis 5.3.2. Product Benchmarking 5.3.3. Strategic Development 5.4. Aleva Neurotherapeutics SA. 5.4.1. Revenue Analysis

5.4.2. Product Benchmarking 5.4.3. Strategic Development Chapter 6. Methodology and Scope 6.1. Research Methodology 6.2. Research Scope & Assumption 6.3. List of Data Sources Browse full report @ http://www.grandviewresearch.com/industry-analysis/deep-brainstimulators-dbs-market

List of Tables 1. Deep Brain Stimulators– Industry Summary & Critical Success Factors (CSFs) 2. Global Deep Brain Stimulators Revenue, 2012 - 2020 3. Global Deep Brain Stimulators Market Revenue By Region, (USD million), 2012 - 2020 4. Global Deep Brain Stimulators Market Revenue by Application, (USD million), 2012 – 2020 5. Global Pain Management Market, 2012 to 2020 (USD million) 6. Global Epilepsy Market, 2012 to 2020 (USD million) 7. Global Essential Tremor Market 2012 to 2020 (USD million) 8. Global Obsessive Compulsive Disorder (OCD) Market 2012 to 2020 (USD million) 9. Global Depression Market, 2012 to 2020 (USD million) 10. Global Dystonia Market, 2012 to 2020 (USD million) 11. Global Parkinson’s Disease Market, 2012 to 2020 (USD million) 12. Global Others Market, 2012 to 2020 (USD million) 13. Global Deep Brain Stimulators Market, By Region, 2012 to 2020 (USD million) 14. North America Deep Brain Stimulators Demand, By Application, (USD million), 2012 – 2020

15. U.S. Deep Brain Stimulators Demand, By Application, (USD million), 2012 – 2020 16. Europe Deep Brain Stimulators Demand, By Application, (USD million), 2012 – 2020 17. Germany Deep Brain Stimulators Demand, By Application, (USD million), 2012 – 2020 18. UK Deep Brain Stimulators Demand, By Application, (USD million), 2012 – 2020 19. Asia Pacific Deep Brain Stimulators Demand, By Application, (USD million), 2012 – 2020 20. Japan Deep Brain Stimulators Demand, By Application, (USD million), 2012 – 2020 21. RoW Deep Brain Stimulators Demand, By Application, (USD million), 2012 – 2020 22. Global Deep Brain Stimulators Market - Competitive Landscape

For More Information visit http://www.grandviewresearch.com/industry-analysis/deepbrain-stimulators-dbs-market

List of Figures 1. Deep Brain Stimulators Market Segmentation 2. Global Deep Brain Stimulators Market Revenue, 2012 - 2020 3. Deep Brain Stimulators Market Dynamics 4. Key Opportunities Prioritized 5. Industry Analysis - Porter's 6. Deep Brain Stimulators PESTEL Analysis, 2012 7. Global Deep Brain Stimulators Market, by Application, (USD million), 2012 – 2020 8. Pain Management Market, By Region, (USD million), 2012 – 2020 9. Epilepsy Market, By Region, (USD million), 2012 – 2020 10. Essential Tremor Market, By Region, (USD million), 2012 – 2020

11. Obsessive Compulsive Disorder Market (OCD), By Region 2012 to 2020 (USD million) 12. Depression Market, By Region 2012 to 2020 (USD million) 13. Dystonia Market, By Region 2012 to 2020 (USD million) 14. Parkinson’s Disease Market, By Region 2012 to 2020 (USD million) 15. Others Market, By Region 2012 to 2020 (USD million) 16. Deep Brain Stimulators Market - Company Market Share Analysis, 2013 (%)

Further key findings from the study suggest: • Parkinson’s disease was the largest application segment of the market in 2013. Use of deep brain stimulators for treating this disease renders symptomatic relief from medicine induced dyskinesia and therefore, these devices are expected to witness a rapid growth in demand during the forecast period. • OCD (obsessive compulsive disorder) was also one of the leading application segments in 2013. DBS has proven to be the most efficient treatment option pertaining to OCD and is expected to witness a rapid growth in usage rates over the next six years. • North America was the largest regional market, accounting for over 50.0% of market share in 2013. Presence of sophisticated healthcare infrastructure and reimbursement policies and increasing awareness levels of patients and healthcare personnel are some key factors expected to drive regional market growth during the forecast period. • Asia Pacific is identified as the most lucrative market. Rapidly improving healthcare infrastructure, presence of high unmet medical needs and increasing healthcare spending levels in the emerging markets of China and India are some factors attributing to its growth. • Some key manufacturers of deep brain stimulators include St. Jude Medical, Medtronic Plc, Boston Scientific Corporation and Aleva Neurotherapeutics SA. • The market is marked by the presence of extensive R&D investments targeting the development of technologically advanced systems catering to new application areas. Moreover, manufacturers participate in endeavors directed towards capitalizing on the untapped opportunities available in the emerging Asia Pacific and Latin American markets.

Request free sample of this Report @ http://www.grandviewresearch.com/industryanalysis/deep-brain-stimulators-dbs-market/request

For the purpose of this study, Grand View Research has segmented the global deep brain stimulators market on the basis of application and region: Global Deep Brain Stimulators Application Outlook (Revenue, USD Million, 2012 – 2020) • Pain Management • Epilepsy • Essential Tremor • Obsessive Compulsive Disorder (OCD) • Depression • Dystonia • Parkinson’s Disease • Others Deep Brain Stimulators Regional Outlook (Revenue, USD Billion, 2012 – 2020) • North America • U.S. • Europe • Germany • UK • Asia Pacific • Japan • RoW

Browse

All

Reports

of

this